Product Images Donepezil Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Donepezil Hydrochloride NDC 46708-296 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
10 mg 30's bottle pack - donepezil 10mg
This text is a label from a medication called Donepezil Hydrochloride USP. It provides information on the dosage and use of the medication, as well as storage instructions. It also includes the NDC code, information on the manufacturer and pharmacist's instructions on dispensing.*
5 mg 30's bottle pack - donepezil 5mg
This is a label of Donepezil Hydrochloride medication manufactured by Alembic Pharmaceuticals Limited in India. It comes in tablet form and is dispensed in tight containers. It is advised to store it at room temperature and the pharmacist should include a patient information sheet. The Lot and EXP numbers are not available.*
Figure 1 - donepezil figure1
Figure 10 - donepezil figure10
The text describes a graph showing the cumulative percentage of patients completing six months of a double-blind treatment, with particular changes from baseline in ADCS-ADL-Severe Scores. The graph is labeled as Figure 10 and displays the data in a line graph format.*
Figure 2 - donepezil figure2
Figure 3 - donepezil figure3
The text presents a figure (Figure 3) that shows the frequency distribution of CIBIC-plus Scores at Week 24. The figure includes a table with percentages of patients that experienced different levels of improvement in their condition (Markedly Improved, Moderately Improved, Minimally Improved, No Change, Minimally Worse, Moderately Worse, Markedly Worse).*
Figure 4 - donepezil figure4
The text describes a figure (Figure 4) showing the time-course of the change from baseline in ADAS-cog score for patients who completed a 15-week drug treatment study. The title of the figure suggests that it is related to drug treatment for some condition, but the specifics are not provided.*
Figure 5 - donepezil figure5
Figure 6 - donepezil figure6
Figure 7 - donepezil figure7
Figure 8 - donepezil figure8
This text appears to be a figure caption from a medical or scientific publication about a study on patients receiving double-blind treatment. The figure is likely a graph that shows the cumulative percentage of patients based on changes from baseline in SIB scores (which is not defined in the text). Therefore, the description is: "Figure caption displaying a graph of the cumulative percentage of patients completing 6 months of double-blind treatment, based on changes from baseline in SIB scores."*
Structure - donepezil structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.